Influence of inflammation and adipocyte biochemical markers on the components of metabolic syndrome

Experimental and Therapeutic Medicine
Dana Carmen ZahaSimona Bungau

Abstract

Metabolic syndrome is associated with increased risk of cardiovascular disease. This study investigated the correlation between adipocyte and inflammation biomarkers, and metabolic syndrome and its components. The study included 80 patients with normal body-mass index and 80 obese patients. The groups were assessed for serum values of adiponectin, leptin and highly sensitive C reactive protein (hsCRP), the homeostatic model assessment of insulin resistance (HOMA-IR), as well as the influence of these biochemical markers on the prevalence of metabolic syndrome and its components. Leptin, HOMA-IR and hsCRP had statistically significant (P<0.01) higher values in the group of obese subjects, while adiponectin had statistically significant (P<0.01) lower values. The prevalence of metabolic syndrome was 35% in the obese group and 5% in the normal weight group. Adiponectin and HOMA-IR were the variables significantly associated with metabolic syndrome (P<0.01), adiponectin/HOMA-IR ratio and leptin/adiponectin ratio were also associated with metabolic syndrome (P<0.01). No relationship was found between metabolic syndrome and hsCRP. Adiponectin and adiponectin/HOMA-IR were associated with all the components of metabolic syndrome and th...Continue Reading

References

Aug 5, 2000·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·M TakahashiY Matsuzawa
Jun 13, 2003·Nature·Toshimasa YamauchiTakashi Kadowaki
Jan 30, 2004·Diabetes Care·Adamandia D KriketosLesley V Campbell
Jan 18, 2005·American Journal of Physiology. Heart and Circulatory Physiology·David C W LauSubodh Verma
Feb 19, 2005·Diabetic Medicine : a Journal of the British Diabetic Association·N A AbdellaS Al Jebely
Sep 27, 2005·Lancet·K George M M AlbertiUNKNOWN IDF Epidemiology Task Force Consensus Group
May 3, 2006·Hypertension·Koji OhashiIichiro Shimomura
Apr 17, 2009·Current Opinion in Lipidology·Sridevi DevarajIshwarlal Jialal
Jul 2, 2009·The Journal of Clinical Endocrinology and Metabolism·Amit KheraJames A de Lemos
Aug 30, 2011·Metabolic Syndrome and Related Disorders·Imen BoumaizaAli Bouslama
Feb 27, 2014·Diabetology & Metabolic Syndrome·Anize D von FrankenbergFernando Gerchman
Aug 12, 2014·BioMed Research International·Ersilia NigroAurora Daniele
Nov 13, 2014·Hormone Molecular Biology and Clinical Investigation·Patricio López-JaramilloStefany Triana-Cubillos
May 22, 2016·Computer Methods and Programs in Biomedicine·Florina Maria Gabor-HarosaFloarea Mocean
Jun 22, 2017·International Journal of Molecular Sciences·Arunkumar E Achari, Sushil K Jain
Feb 27, 2018·Current Hypertension Reports·Mohammad G Saklayen
Jun 1, 2018·Oxidative Medicine and Cellular Longevity·Mohamed M Abdel-DaimNikhat J Siddiqi
Jan 4, 2019·International Journal of Molecular Sciences·Hang XuShaodong Guo
Jan 27, 2019·Experimental and Therapeutic Medicine·Ovidiu GrigoreConstantin Caruntu
Apr 2, 2019·Metabolic Syndrome and Related Disorders·Shalkar AdambekovFaina Linkov
Jul 16, 2019·Metabolic Syndrome and Related Disorders·Rajesh RajputParul Ahlawat
Aug 7, 2019·Experimental and Therapeutic Medicine·Mihaela Adriana IlieDaniel Boda
Aug 31, 2019·Oxidative Medicine and Cellular Longevity·Mohamed M Abdel-DaimAtanas G Atanasov

❮ Previous
Next ❯

Citations

Apr 4, 2021·International Journal of Molecular Sciences·Tapan BehlSimona Bungau

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

© 2022 Meta ULC. All rights reserved